Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Chapman

Showing results (861-870 of 1,011) with videos related to

Pageof 102
Sort By:
Stem Cell Research & Therapy|January 9, 2019
Clonal derivation of white and brown adipocyte progenitor cell lines from human pluripotent stem cellsMichael D West, Ching-Fang Chang, Dana Larocca, et al.
Cancer Discovery|March 5, 2014
Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignanciesOmar Abdel-Wahab, Virginia M Klimek, Alisa A Gaskell, et al.
Journal of Internal Medicine|March 12, 2014
Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses studyA G Vandell, C W McDonough, Y Gong, et al.
Metabolomics : Official Journal of the Metabolomic Society|February 21, 2017
Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approachFelipe A de Oliveira, Mohamed H Shahin, Yan Gong, et al.
Pharmacogenetics and Genomics|October 6, 2018
Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazideSonal Singh, Zhiying Wang, Mohamed H Shahin, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Blended Genome Exome (BGE) as a Cost Efficient Alternative to Deep Whole Genomes or ArraysMatthew DeFelice, Jonna L Grimsby, Daniel Howrigan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trialEmilie Cornec-Le Gall, Jaime D Blais, Maria V Irazabal, et al.
Journal of Hypertension|January 29, 2013
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diureticsCaitrin W McDonough, Sarah E Burbage, Julio D Duarte, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 13, 2019
Effect of plasma MicroRNA on antihypertensive response to beta blockers in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studiesMohamed H Solayman, Taimour Y Langaee, Yan Gong, et al.
Journal of the American Society of Nephrology : JASN|June 22, 2007
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney diseaseSandro Rossetti, Mark B Consugar, Arlene B Chapman, et al.
Pageof 102

Showing results (861-870 of 1,011) with videos related to

Sort By:
Pageof 102
Stem Cell Research & Therapy|January 9, 2019
Clonal derivation of white and brown adipocyte progenitor cell lines from human pluripotent stem cellsMichael D West, Ching-Fang Chang, Dana Larocca, et al.
Cancer Discovery|March 5, 2014
Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignanciesOmar Abdel-Wahab, Virginia M Klimek, Alisa A Gaskell, et al.
Journal of Internal Medicine|March 12, 2014
Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses studyA G Vandell, C W McDonough, Y Gong, et al.
Metabolomics : Official Journal of the Metabolomic Society|February 21, 2017
Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approachFelipe A de Oliveira, Mohamed H Shahin, Yan Gong, et al.
Pharmacogenetics and Genomics|October 6, 2018
Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazideSonal Singh, Zhiying Wang, Mohamed H Shahin, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Blended Genome Exome (BGE) as a Cost Efficient Alternative to Deep Whole Genomes or ArraysMatthew DeFelice, Jonna L Grimsby, Daniel Howrigan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trialEmilie Cornec-Le Gall, Jaime D Blais, Maria V Irazabal, et al.
Journal of Hypertension|January 29, 2013
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diureticsCaitrin W McDonough, Sarah E Burbage, Julio D Duarte, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 13, 2019
Effect of plasma MicroRNA on antihypertensive response to beta blockers in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studiesMohamed H Solayman, Taimour Y Langaee, Yan Gong, et al.
Journal of the American Society of Nephrology : JASN|June 22, 2007
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney diseaseSandro Rossetti, Mark B Consugar, Arlene B Chapman, et al.
Pageof 102